Fate of D3 Mouse Embryonic Stem Cells Exposed to X-rays or Carbon Ions
Overview
Genetics
Toxicology
Affiliations
The risk of radiation exposure during embryonic development is still a major problem in radiotoxicology. In this study we investigated the response of the murine embryonic stem cell (mESC) line D3 to two radiation qualities: sparsely ionizing X-rays and densely ionizing carbon ions. We analyzed clonogenic cell survival, proliferation, induction of chromosome aberrations as well as the capability of cells to differentiate to beating cardiomyocytes up to 3 days after exposure. Our results show that, for all endpoints investigated, carbon ions are more effective than X-rays at the same radiation dose. Additionally, in long term studies (≥8 days post-irradiation) chromosomal damage and the pluripotency state were investigated. These studies reveal that pluripotency markers are present in the progeny of cells surviving the exposure to both radiation types. However, only in the progeny of X-ray exposed cells the aberration frequency was comparable to that of the control population, while the progeny of carbon ion irradiated cells harbored significantly more aberrations than the control, generally translocations. We conclude that cells surviving the radiation exposure maintain pluripotency but may carry stable chromosomal rearrangements after densely ionizing radiation.
Radiation Response of Murine Embryonic Stem Cells.
Hellweg C, Shinde V, Srinivasan S, Henry M, Rotshteyn T, Baumstark-Khan C Cells. 2020; 9(7).
PMID: 32660081 PMC: 7408589. DOI: 10.3390/cells9071650.
Lee S, Wu G, Choi N, Lee H, Bang J, Lee Y Mol Cells. 2018; 41(7):631-638.
PMID: 29991673 PMC: 6078851. DOI: 10.14348/molcells.2018.2294.
Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer.
Sylvester C, Abe J, Patel Z, Grande-Allen K Front Cardiovasc Med. 2018; 5:5.
PMID: 29445728 PMC: 5797745. DOI: 10.3389/fcvm.2018.00005.
Rebuzzini P, Zuccotti M, Redi C, Garagna S Cell Mol Life Sci. 2016; 73(13):2453-66.
PMID: 26961132 PMC: 11108315. DOI: 10.1007/s00018-016-2171-8.
Muralidharan S, Sasi S, Zuriaga M, Hirschi K, Porada C, Coleman M Front Oncol. 2015; 5:231.
PMID: 26528440 PMC: 4604322. DOI: 10.3389/fonc.2015.00231.